Tsakiri, M.; Tsichlis, I.; Zivko, C.; Demetzos, C.; Mahairaki, V.
Lipidic Nanoparticles, Extracellular Vesicles and Hybrid Platforms as Advanced Medicinal Products: Future Therapeutic Prospects for Neurodegenerative Diseases. Pharmaceutics 2024, 16, 350.
https://doi.org/10.3390/pharmaceutics16030350
AMA Style
Tsakiri M, Tsichlis I, Zivko C, Demetzos C, Mahairaki V.
Lipidic Nanoparticles, Extracellular Vesicles and Hybrid Platforms as Advanced Medicinal Products: Future Therapeutic Prospects for Neurodegenerative Diseases. Pharmaceutics. 2024; 16(3):350.
https://doi.org/10.3390/pharmaceutics16030350
Chicago/Turabian Style
Tsakiri, Maria, Ioannis Tsichlis, Cristina Zivko, Costas Demetzos, and Vasiliki Mahairaki.
2024. "Lipidic Nanoparticles, Extracellular Vesicles and Hybrid Platforms as Advanced Medicinal Products: Future Therapeutic Prospects for Neurodegenerative Diseases" Pharmaceutics 16, no. 3: 350.
https://doi.org/10.3390/pharmaceutics16030350
APA Style
Tsakiri, M., Tsichlis, I., Zivko, C., Demetzos, C., & Mahairaki, V.
(2024). Lipidic Nanoparticles, Extracellular Vesicles and Hybrid Platforms as Advanced Medicinal Products: Future Therapeutic Prospects for Neurodegenerative Diseases. Pharmaceutics, 16(3), 350.
https://doi.org/10.3390/pharmaceutics16030350